Literature DB >> 2393986

Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia--half reperfused and half not reperfused.

W Ganz1, I Watanabe, K Kanamasa, J Yano, D S Han, M C Fishbein.   

Abstract

The purpose of this study was to confirm or disprove the existence of reperfusion-induced extension of necrosis. To avoid the effect of the variability of collateral circulation when groups of dogs are compared, we compared the effect of reperfusion and nonreperfusion on myocardial necrosis in a single ischemic territory, half of which was reperfused and half of which was not. The left anterior descending coronary artery (LAD) territory between its last diagonal branch and the apex was studied because it was found to have uniform collateral blood flow. In 20 dogs, the LAD was occluded for 90-240 minutes to produce necrosis of different degrees of transmurality. Before release of this occlusion, the LAD was occluded distally halfway to the apex to keep the distal half nonreperfused. After 5 minutes of proximal reperfusion. Monastral blue dye was injected into the left atrium for demarcation of the reperfused region, and the heart was arrested, excised, cut parallel to the LAD, and placed into triphenyl tetrazolium chloride (TTC) solution for delineation of the region of necrosis. The validity of TTC staining under the conditions of this study was confirmed by light and electron microscopy. The transmurality of necrosis, measured within 1 or 0.5 cm on either side of the boundary, ranged from 30% to 88% of wall thickness and was not different in the reperfused compared with the nonreperfused region (paired t test). Reperfusion did not advance the epicardial edge of necrosis compared with the nonreperfused region. In conclusion, at 5 minutes after reperfusion, comparison of necrosis in the reperfused and nonreperfused halves of a single ischemic territory could not demonstrate an extension of necrosis by reperfusion.

Entities:  

Mesh:

Year:  1990        PMID: 2393986     DOI: 10.1161/01.cir.82.3.1020

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Does Reperfusion Injury Exist?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Reperfusion Injury: Fact, Fiction, or Simply Unresolvable?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Direct Demonstration in Dogs of the Absence of Lethal Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

4.  Little Evidence for Lethal Reperfusion Injury to Cardiomyocytes.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

5.  Reperfusion Stimulated Inflammatory Response: Role in Lethal Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

6.  W(h)ither Myocardial Reperfusion Injury?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 7.  Coronary vasoregulation in health and disease.

Authors:  John G Kingma; Jacques R Rouleau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

8.  Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70.

Authors:  S U Trost; J H Omens; W J Karlon; M Meyer; R Mestril; J W Covell; W H Dillmann
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

9.  rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model.

Authors:  Jingyu Zhang; Zhigang Yu; Zhiqiang Yu; Zichao Yang; Hong Zhao; Luran Liu; Jiexu Zhao
Journal:  Int J Clin Exp Pathol       Date:  2011-06-16

10.  Stuttering Reperfusion of Ischemic Myocardium Does Not Exacerbate Myocardial Infarction: Evidence Against Lethal Cell Reperfusion Injury in the Rabbit.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.